Non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly.

Autor: Ajam T; Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers , Milwaukee, WI, USA., Cumpian TL; Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers , Milwaukee, WI, USA.; Center for Advanced Atrial Fibrillation Therapies , Milwaukee, WI USA., Tilkens BL; Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers , Milwaukee, WI, USA., Jahangir IA; Loyola University , Chicago, IL, USA., Frost J; Pharmacy Services, Advocate Aurora Health , Milwaukee, WI, USA., Ceretto C; Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers , Milwaukee, WI, USA.; Center for Advanced Atrial Fibrillation Therapies , Milwaukee, WI USA., Jahangir A; Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers , Milwaukee, WI, USA.; Center for Advanced Atrial Fibrillation Therapies , Milwaukee, WI USA.

Publikováno v: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2020 Dec; Vol. 13 (12), pp. 1309-1327. Date of Electronic Publication: 2020 Nov 11.